TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI® (ublituximab-xiiy), in adults with treatment-resistant schizophrenia. The Phase 2 ...
The program offers college and vocational training to prison inmates and youth at Juvenile Hall in SLO County.
Discover why meaningful growth requires both striving toward virtue and descending into the hidden fears and assumptions that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results